Von Eschenbach Andrew C. - Net Worth and Insider Trading

Von Eschenbach Andrew C. Net Worth

The estimated net worth of Von Eschenbach Andrew C. is at least $337,274 dollars as of 2024-04-16. Von Eschenbach Andrew C. is the Director of Bausch Health Companies Inc and owns about 38,647 shares of Bausch Health Companies Inc (BHC) stock worth over $333,524. Von Eschenbach Andrew C. is also the Director of Lineage Cell Therapeutics Inc and owns about 3,000 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $3,750. Details can be seen in Von Eschenbach Andrew C.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Von Eschenbach Andrew C. has not made any transactions after 2021-08-05 and currently still holds the listed stock(s).

Transaction Summary of Von Eschenbach Andrew C.

To

Von Eschenbach Andrew C. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Von Eschenbach Andrew C. owns 8 companies in total, including Bausch Health Companies Inc () , Asterias Biotherapeutics Inc () , and Lineage Cell Therapeutics Inc () among others .

Click here to see the complete history of Von Eschenbach Andrew C.’s form 4 insider trades.

Insider Ownership Summary of Von Eschenbach Andrew C.

Ticker Comapny Transaction Date Type of Owner
Bausch Health Companies Inc 2021-08-05 director
Asterias Biotherapeutics Inc 2014-04-01 director
Lineage Cell Therapeutics Inc 2013-08-12 director
Radius Health Inc 2022-08-15 director
Celularity Inc 2021-11-09 director
Bausch & Lomb Corp 2022-05-05 director
TriSalus Life Sciences Inc 2023-08-10 director
MedTech Acquisition Corp 2023-08-10 director

Von Eschenbach Andrew C. Latest Holdings Summary

Von Eschenbach Andrew C. currently owns a total of 2 stocks. Among these stocks, Von Eschenbach Andrew C. owns 38,647 shares of Bausch Health Companies Inc (BHC) as of August 5, 2021, with a value of $333,524 and a weighting of 98.89%. Von Eschenbach Andrew C. also owns 3,000 shares of Lineage Cell Therapeutics Inc (LCTX) as of August 12, 2013, with a value of $3,750 and a weighting of 1.11%.

Latest Holdings of Von Eschenbach Andrew C.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BHC Bausch Health Companies Inc 2021-08-05 38,647 8.63 333,524
LCTX Lineage Cell Therapeutics Inc 2013-08-12 3,000 1.25 3,750

Holding Weightings of Von Eschenbach Andrew C.


Von Eschenbach Andrew C. Form 4 Trading Tracker

According to the SEC Form 4 filings, Von Eschenbach Andrew C. has made a total of 2 transactions in Bausch Health Companies Inc (BHC) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Bausch Health Companies Inc is the acquisition of 1,400 shares on August 5, 2021, which cost Von Eschenbach Andrew C. around $36,316.

According to the SEC Form 4 filings, Von Eschenbach Andrew C. has made a total of 0 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years. The most-recent trade in Lineage Cell Therapeutics Inc is the acquisition of 3,000 shares on August 12, 2013, which cost Von Eschenbach Andrew C. around $11,070.

Insider Trading History of Von Eschenbach Andrew C.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Von Eschenbach Andrew C. Trading Performance

GuruFocus tracks the stock performance after each of Von Eschenbach Andrew C.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Von Eschenbach Andrew C. is 1.95%. GuruFocus also compares Von Eschenbach Andrew C.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Von Eschenbach Andrew C. within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Von Eschenbach Andrew C.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Von Eschenbach Andrew C.

Average Relative Return

-10.63%

Average relative return per transaction

Outperforming Transactions

33%

1 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 3.3 1.95 -11.55 -10.63 -15.19 -14.22
Relative Return to S&P 500(%) 3.69 -5.17 -19.93 -25.07 -26.27 -23.81

Von Eschenbach Andrew C. Ownership Network

Ownership Network List of Von Eschenbach Andrew C.

No Data

Ownership Network Relation of Von Eschenbach Andrew C.


Von Eschenbach Andrew C. Owned Company Details

What does Bausch Health Companies Inc do?

Who are the key executives at Bausch Health Companies Inc?

Von Eschenbach Andrew C. is the director of Bausch Health Companies Inc. Other key executives at Bausch Health Companies Inc include EVP & General Counsel Seana Carson , SVP & Controller & CAO John S Barresi , and EVP & Chief Financial Officer Tom George Vadaketh .

Bausch Health Companies Inc () Insider Trades Summary

Over the past 18 months, Von Eschenbach Andrew C. made no insider transaction in Bausch Health Companies Inc (). Other recent insider transactions involving Bausch Health Companies Inc () include a net sale of 8,515 shares made by Seana Carson ,

In summary, during the past 3 months, insiders sold 0 shares of Bausch Health Companies Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,515 shares of Bausch Health Companies Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 8,515 shares.

Bausch Health Companies Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Bausch Health Companies Inc Insider Transactions

No Available Data

Von Eschenbach Andrew C. Mailing Address

Above is the net worth, insider trading, and ownership report for Von Eschenbach Andrew C.. You might contact Von Eschenbach Andrew C. via mailing address: C/o Blco, 400 Somerset Corporate Blvd., Bridgewater Nj 08807.

Discussions on Von Eschenbach Andrew C.

No discussions yet.